Trefoil Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Trefoil Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Dose Escalation TTHX1114 Ophthalmic Solution (NCT05769920) | Trefoil Therapeutics, Inc. | 2022-12-06 |
| A Safety and Efficacy Trial of TTHX1114 in People With CED (NCT04812067) | Trefoil Therapeutics, Inc. | 2021-11-30 |
| TTHX1114(NM141) in Combination With DWEK/DSO (NCT04676737) | Trefoil Therapeutics, Inc. | 2021-02-01 |
| A Phase 1/ Phase 2 Study of TTHX1114(NM141) (NCT04520321) | Trefoil Therapeutics, Inc. | 2020-08-19 |
Track Trefoil Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.